Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
2 "Intestinal fistula"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
IBD
Perianal fistulizing lesions of Crohn’s disease are associated with long-term behavior and its transition: a Chinese cohort study
Wei Zhan, Xiaoyin Bai, Hong Yang, Jiaming Qian
Intest Res 2024;22(4):484-495.   Published online July 15, 2024
DOI: https://doi.org/10.5217/ir.2024.00021
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
Crohn’s disease (CD) has a progressive nature and commonly perianal involvement. The aim of this study is to assess the prevalence, surgical treatment, and outcome of perianal fistulizing CD with associated risk factors in a large Chinese cohort.
Methods
Hospitalized patients diagnosed with CD in our center were consecutively enrolled between January 2000 and December 2018. Transition of disease behavior was classified according to the presence or absence of penetrating behavior (B3 in the Montreal classification) at diagnosis and at a median follow-up of 102 months.
Results
A total of 504 patients were included, of whom 207 (41.1%) were classified as B3 and 348 (69.0%) as L2/3 at follow-up. Transition of behavior to B3 was observed in 86 patients (17.1%). The incidence of perianal fistulizing lesions was 10.9% at 10 years with a final prevalence of 27.0% (n = 136) at the end of follow-up. Multivariate Cox regression identified independent risks of perianal fistulizing lesions for persistent B3 (hazard ratio, 4.72; 95% confidence interval, 1.91–11.66) and behavior transition of progressed to B3 (hazard ratio, 9.90; 95% confidence interval, 4.60–21.33). Perianal surgical treatments were performed in 104 patients (20.6%). Thirty-six cases (7.1%) were refractory, and it is independently associated with behavior of persistent B3 (P= 0.011).
Conclusions
Perianal fistulizing lesions occurred frequently in Chinese CD patients. Its incidence and refractory outcome were closely associated with the penetrating CD behavior. An additional risk of perianal fistulizing lesions was indicated for CD patients with behavior of progressing to B3, suggesting further attention.
  • 1,967 View
  • 127 Download
Close layer
Review
IBD
An overview of the role of exclusive enteral nutrition for complicated Crohn’s disease
Mustafa Adamji, Andrew S Day
Intest Res 2019;17(2):171-176.   Published online December 3, 2018
DOI: https://doi.org/10.5217/ir.2018.00079
AbstractAbstract PDFPubReaderePub
The role and efficacy of exclusive enteral nutrition (EEN) in the treatment of luminal Crohn’s disease (CD) has been well established over the last 2 decades. Consequently, in many centers nutritional therapy is now considered first line therapy in the induction of remission of active CD. However, the use of nutritional therapy in complicated CD has yet to be fully determined. This article aimed to review case reports and clinical trials published in the last decade that have considered and evaluated nutritional therapy in the setting of complicated CD in children and adults. Published literature focusing upon the use of nutritional therapy as part of medical therapy in the management of complicated CD were identified and reviewed. Although there continue to be various interventions utilized for complicated CD, the currently available literature demonstrates that nutritional therapies, especially EEN, have important roles in the management of these complex scenarios. Further assessments, involving large numbers of patients managed with consistent approaches, are required to further substantiate these roles.

Citations

Citations to this article as recorded by  
  • Adjunct polymeric exclusive enteral nutrition helps achieve biochemical remission in active Crohn’s disease in adults irrespective of disease location and concomitant corticosteroid use
    Hellen Kuo, Katrina Tognolini, Rumbidzai Mutsekwa, Dheeraj Shukla, Laura Willmann, Hadi Moattar, Alexander Dorrington, Naveed Ishaq, Maneesha Bhullar, John Edwards, Waled Mohsen, Pradeep Kakkadasam Ramaswamy
    Frontline Gastroenterology.2025; 16(1): 3.     CrossRef
  • Positionspapier der Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE) zum zulassungsüberschreitenden Gebrauch von für Erwachsene mit CED zugelassenen Biologika und Signalinhibitoren bei Kindern und Jugendlichen
    Jan Däbritz, Martin Classen, Kathrin Krohn, Andreas Krahl, Stephan Buderus, Elke Lainka, Jan de Laffolie, Carsten Posovszky
    Zeitschrift für Gastroenterologie.2025; 63(03): 255.     CrossRef
  • Understanding Role of Nutrition in Inflammatory Bowel Disease: A Comprehensive Review With Incorporation of AGA Update
    Galvin Dhaliwal, Dushyant Singh Dahiya, Ashvin Singh Dhaliwal, Hassam Ali, Manesh Kumar Gangwani, Fouad Jaber, Saqr Alsakarneh, Islam Mohamed, Umar Hayat, Bhanu Siva Mohan Pinnam, Sahib Singh, Sasha Mangray, Stephen Bickston
    Journal of Gastroenterology and Hepatology.2025;[Epub]     CrossRef
  • Mycobacterium avium ssp. paratuberculosis and Crohn’s Disease—Diagnostic Microbiological Investigations Can Inform New Therapeutic Approaches
    John M. Aitken, Jack E. Aitken, Gaurav Agrawal
    Antibiotics.2024; 13(2): 158.     CrossRef
  • Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline
    Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignass, Robert Ehehalt, Christoph-Thomas Germer, P. C. Grunert, Ulf Helwig, Karoline Horisberger, Klaus Herrlinger, Peter Kienle, Torsten Kucharzik, Jost Langhorst, Christian Maaser,
    Zeitschrift für Gastroenterologie.2024; 62(08): 1229.     CrossRef
  • Mechanisms of Action of Exclusive Enteral Nutrition and Other Nutritional Therapies in Crohn’s Disease
    Ramasatyaveni Geesala, Pratik Gongloor, Neeraja Recharla, Xuan-Zheng Shi
    Nutrients.2024; 16(21): 3581.     CrossRef
  • Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis
    Aleksandra Jatkowska, Bernadette White, Konstantinos Gkikas, John Paul Seenan, Jonathan MacDonald, Konstantinos Gerasimidis
    Journal of Crohn's and Colitis.2024;[Epub]     CrossRef
  • Is Salt at Fault? Dietary Salt Consumption and Inflammatory Bowel Disease
    Rebecca Kuang, Stephen J D O’Keefe, Claudia Ramos del Aguila de Rivers, Filippos Koutroumpakis, David G Binion
    Inflammatory Bowel Diseases.2023; 29(1): 140.     CrossRef
  • The Role of the Gut Microbiota in the Relationship Between Diet and Human Health
    Bryce K. Perler, Elliot S. Friedman, Gary D. Wu
    Annual Review of Physiology.2023; 85(1): 449.     CrossRef
  • Global research trends on diet and nutrition in Crohn’s disease
    Muna Shakhshir, Sa'ed H Zyoud
    World Journal of Gastroenterology.2023; 29(20): 3203.     CrossRef
  • Enterale Ernährungstherapien beim pädiatrischen M. Crohn Anwendungen und Wirkweise
    André Hörning, Anjona Schmidt-Choudhury
    Aktuelle Ernährungsmedizin.2023; 48(03): 183.     CrossRef
  • Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter
    Nikolas Dovrolis, Anastasia Moschoviti, Smaragdi Fessatou, George Karamanolis, George Kolios, Maria Gazouli
    Biomedicines.2023; 11(7): 1979.     CrossRef
  • Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases
    Hala Elzayat, Ghaidaa Mesto, Farah Al-Marzooq
    Nutrients.2023; 15(15): 3377.     CrossRef
  • Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
    Catherine O’Reilly, Susan Mills, Mary C. Rea, Aonghus Lavelle, Subrata Ghosh, Colin Hill, R. Paul Ross
    Microbiome Research Reports.2023;[Epub]     CrossRef
  • Current understanding of the aetiology and pathogenesis of inflammatory bowel diseases (Part 2): the role of the microbiome and nutritional factors
    A. I. Khavkin, K. M. Nikolaychuk, E. V. Shrayner, D. R. Shaimardanova, A. S. Veremenko, I. D. Levchenko, P. Ya. Platonova, M. F. Novikova, V. V. Dudurich
    Experimental and Clinical Gastroenterology.2023; (12): 164.     CrossRef
  • FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence
    Catarina D. Simões, Marta Maganinho, Ana S. Sousa
    European Journal of Nutrition.2022; 61(3): 1187.     CrossRef
  • Effects of Olive Oil and Its Components on Intestinal Inflammation and Inflammatory Bowel Disease
    Josip Vrdoljak, Marko Kumric, Marino Vilovic, Dinko Martinovic, Iris Jeroncic Tomic, Mladen Krnic, Tina Ticinovic Kurir, Josko Bozic
    Nutrients.2022; 14(4): 757.     CrossRef
  • Exclusive enteral nutrition: An optimal care pathway for use in children with active luminal Crohn's disease
    Deirdre Burgess, Kathleen H McGrath, Caitlin Watson, Tanya Collins, Stephanie Brown, Katie Marks, Kate Dehlsen, Kim Herbison, Emma Landorf, Laura Benn, Julia Fox, Ming Liew
    Journal of Paediatrics and Child Health.2022; 58(4): 572.     CrossRef
  • Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004
    Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Oc
    Zeitschrift für Gastroenterologie.2022; 60(03): 332.     CrossRef
  • The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
    Panu Wetwittayakhlang, Alex Al Khoury, Gustavo Drügg Hahn, Peter Laszlo Lakatos
    Journal of Clinical Medicine.2022; 11(11): 3045.     CrossRef
  • Laser Therapy in Perianal Fistulas
    Mircea Sandor, Maur Sebastian Horgos, Ioan Lucian Borza, Rodica Negrean, Mihai Botea, Szuhai Erika Bimbo, Anca Huniadi, Liliana Sachelarie, Loredana Liliana Hurjui, Irina Mihaela Jemnoschi Hreniuc
    Applied Sciences.2022; 12(23): 12433.     CrossRef
  • Enterale Ernährungstherapien beim pädiatrischen M. Crohn
    André Hörning, Anjona Schmidt-Choudhury
    Kinder- und Jugendmedizin.2022; 22(06): 439.     CrossRef
  • Dietary patterns, beliefs and behaviours among individuals with inflammatory bowel disease: a cross‐sectional study
    K. J. Kamp, B. Pennings, D. Javelli, G. Wyatt, B. Given
    Journal of Human Nutrition and Dietetics.2021; 34(2): 257.     CrossRef
  • Alterations in drug disposition in older adults: a focus on geriatric syndromes
    Dorsa Maher, Nagham Ailabouni, Arduino A. Mangoni, Michael D. Wiese, Emily Reeve
    Expert Opinion on Drug Metabolism & Toxicology.2021; 17(1): 41.     CrossRef
  • Nutritional Therapy Strategies in Pediatric Crohn’s Disease
    Charlotte M. Verburgt, Mohammed Ghiboub, Marc A. Benninga, Wouter J. de Jonge, Johan E. Van Limbergen
    Nutrients.2021; 13(1): 212.     CrossRef
  • Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice
    Fuzheng Tao, Xi Xing, Jiannong Wu, Ronglin Jiang, Tamil Selvan Anthonymuthu
    PLOS ONE.2021; 16(3): e0248482.     CrossRef
  • Fish Sidestream-Derived Protein Hydrolysates Suppress DSS-Induced Colitis by Modulating Intestinal Inflammation in Mice
    Maria G. Daskalaki, Konstantinos Axarlis, Tone Aspevik, Michail Orfanakis, Ourania Kolliniati, Ioanna Lapi, Maria Tzardi, Eirini Dermitzaki, Maria Venihaki, Katerina Kousoulaki, Christos Tsatsanis
    Marine Drugs.2021; 19(6): 312.     CrossRef
  • Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
    Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja
    Intestinal Research.2021; 19(3): 291.     CrossRef
  • Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea
    Hyun Jin Kim, Seak Hee Oh, Sung Hee Lee, Yu-Bin Kim, Dae Yeon Kim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Kyung Mo Kim
    Gut and Liver.2021; 15(6): 851.     CrossRef
  • The Effect of Formula-based Nutritional Treatment on Colitis in a Murine Model
    Sooyoung Jang, Younjuong Kim, Changjun Lee, Bomi Kwon, Jihye Noh, Jai J. Jee, Sang Sun Yoon, Hong Koh, Sowon Park
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • Efficacy of Exclusive Enteral Nutrition in Pediatric Crohn’s Disease
    Luís Rodrigues, Sofia Moeda, Helena Loreto, Sara Azevedo, Inês Asseiceira, Catarina Maltez, Ana Fernandes, Ana Paula Mourato, Ana Isabel Lopes
    Nutrición Clínica y Dietética Hospitalaria.2021;[Epub]     CrossRef
  • 9,455 View
  • 305 Download
  • 30 Web of Science
  • 31 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP